Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald P Novak

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
Carisbamate (RWJ-333369)Gerald P Novak, Michael Kelley, Peter Zannikos, et al.
Epilepsy & Behavior : E&B|August 23, 2021
Individuals who develop drug-resistant epilepsy within a year after initial diagnosis have higher burden of mental and physical diseases one-year prior to epilepsy diagnosis as compared to those whose seizures were controlled during the same intervalRachel E Teneralli, M Soledad Cepeda, David M Kern, et al.
BMC Genomics|September 1, 2023
Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestatQingqin S Li, Stephan Francke, Jan Snoeys, et al.
Journal of Alzheimer'S Disease : JAD|August 13, 2014
Optimizing regions-of-interest composites for capturing treatment effects on brain amyloid in clinical trialsVolha Tryputsen, Allitia DiBernardo, Mahesh Samtani, et al.
Journal of Alzheimer'S Disease : JAD|February 27, 2018
Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive ImpairmentDai Wang, Tim Schultz, Gerald P Novak, et al.
Headache|February 19, 2009
Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trialRoger K Cady, Ninan Mathew, Hans-Christoph Diener, et al.
Frontiers in Aging Neuroscience|July 25, 2022
Practice Effect of Repeated Cognitive Tests Among Older Adults: Associations With Brain Amyloid Pathology and Other Influencing FactorsBang Zheng, Chinedu Udeh-Momoh, Tamlyn Watermeyer, et al.
Epilepsy Research|April 24, 2007
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled studyDorothée G A Kasteleijn-Nolst Trenité, Jacqueline A French, Edouard Hirsch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 29, 2023
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)Bruce Albala, Eline Appelmans, Ramona Burress, et al.
Frontiers in Aging Neuroscience|July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative DataIsabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
Carisbamate (RWJ-333369)Gerald P Novak, Michael Kelley, Peter Zannikos, et al.
Epilepsy & Behavior : E&B|August 23, 2021
Individuals who develop drug-resistant epilepsy within a year after initial diagnosis have higher burden of mental and physical diseases one-year prior to epilepsy diagnosis as compared to those whose seizures were controlled during the same intervalRachel E Teneralli, M Soledad Cepeda, David M Kern, et al.
BMC Genomics|September 1, 2023
Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestatQingqin S Li, Stephan Francke, Jan Snoeys, et al.
Journal of Alzheimer'S Disease : JAD|August 13, 2014
Optimizing regions-of-interest composites for capturing treatment effects on brain amyloid in clinical trialsVolha Tryputsen, Allitia DiBernardo, Mahesh Samtani, et al.
Journal of Alzheimer'S Disease : JAD|February 27, 2018
Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive ImpairmentDai Wang, Tim Schultz, Gerald P Novak, et al.
Headache|February 19, 2009
Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trialRoger K Cady, Ninan Mathew, Hans-Christoph Diener, et al.
Frontiers in Aging Neuroscience|July 25, 2022
Practice Effect of Repeated Cognitive Tests Among Older Adults: Associations With Brain Amyloid Pathology and Other Influencing FactorsBang Zheng, Chinedu Udeh-Momoh, Tamlyn Watermeyer, et al.
Epilepsy Research|April 24, 2007
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled studyDorothée G A Kasteleijn-Nolst Trenité, Jacqueline A French, Edouard Hirsch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 29, 2023
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)Bruce Albala, Eline Appelmans, Ramona Burress, et al.
Frontiers in Aging Neuroscience|July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative DataIsabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Pageof 2